Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
20 - 25
EC/CAS
2451-62-9
Name of the chemical
1,3,5-Tris(oxiran-2-ylmethyl)-1,3,5-triazinane-2,4,6-trione (TGIC)
Concentration
5 - 10
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
1 - 5
General Information
Revision date
2007-06-26
Product name
Light Gray Matte
Emergency telephone
1-800-424-9300, 1-703-527-3887
Icons in SDS
Company Information
company name
HSE Coordinator (
e-mail address of the competent person responsible for the Safety Data Sheet
HSEcoordinator@Spraylat.com
Section 2
SECTION 2: Hazards identification
(29 CFR 1910.1200) Physical state : Solid. [Powder.]
Principle Routes of Exposure
Dermal contact. Eye contact. Inhalation. Ingestion.
Potential Acute Health Effects
Inhalation : Slightly irritating to the respiratory system. Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure. Ingestion : No known significant effects or critical hazards. Skin : Slightly irritating to the skin. Eyes : Slightly irritating to the eyes. Potential chronic health effects
Potential chronic health
Contains material that can cause target organ damage. Carcinogenicity : Contains material which may cause cancer, based on animal data. Risk of cancer depends on duration and level of exposure. Mutagenicity : No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects : No known significant effects or critical hazards. Fertility effects : No known significant effects or critical hazards. Target organs : Contains material which causes damage to the following organs: lungs, upper respiratory tract, skin, eye, lens or cornea. Over-exposure signs/symptoms Inhalation : Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion : No specific data. Skin : Adverse symptoms may include the following: irritation redness Eyes : Adverse symptoms may include the following: irritation watering redness Medical conditions aggravated by over- exposure : Pre-existing disorders involving any target organs mentioned in this MSDS as being at risk may be aggravated by over-exposure to this product. See toxicological information (section 11)
